>
WEB Gilead researchers have developed 12 HIV medications including the first single-tablet regimen to treat HIV the first antiretroviral for pre. Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024. WEB Gilead researchers have developed 12 HIV medications including the first single-tablet regimen to treat HIV the first antiretroviral for pre. WEB GENEVA 10 July 2024 UNAIDS has welcomed the release of Gilead Sciences trial results on the injectable long-acting HIV medicine Lenacapavir. WEB Gilead is studying the safety and efficacy of lenacapavir for HIV prevention in multiple ongoing clinical studies Please see below for the US..